Larimar Therapeutics Reports Second Quarter 2025 Financial Results
Go back to Larimar Therapeutics Reports Second Quarter 2025 Financial Results| (NASDAQ: LRMR) | Delayed: 3.17 +0.09 (2.92%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.08 | 52 Week High | $ | |||
| Open | $3.04 | 52 Week Low | $ | |||
| Day High | $3.23 | P/E | N/A | |||
| Day Low | $3.03 | EPS | $ | |||
| Volume | 1,673,056 | |||||

